FFAR3 and sleep apnea syndrome: Butyrate or GPR41/Olfr78 silencing reduces inflammation and sympathetic outflow in the hypothalamic paraventricular nucleus, while colonic acetate infusion in sleep apnea-induced HTN lowers neuroinflammation, microglia activation, and BP [32,34].